An uncounted number of extra people have died from AIDS and 2.5 million have lost access to medicine to block the spread of ...

Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...

Activities staff member Robert Hardrick teaches chair tai chi for residents of Broadway House for Continuing Care in New Jersey. (Photo: Courtesy of Broadway House) Nursing home patients with HIV may ...

Even before the crisis, the global AIDS response was severely underfunded, with access to $18.7 billion in 2024 — 17 percent below what was needed, Byanyima said. Already last year, some 9.2 million ...

Nov 2 (Reuters) - About half of HIV patients on antiretroviral therapy skipped their medications whenever they were drinking alcohol, according to a U.S. study - an ill-advised behavior that ...

Public health officials are urging residents across South Central Idaho to take precautions after new data revealed a sharp ...

GENEVA (Reuters) -People living with HIV have died due to service disruptions caused by major funding cuts, while millions of ...